EMUGEN Trademark

Trademark Overview

On Tuesday, March 31, 2026, a trademark application was filed for EMUGEN with the United States Patent and Trademark Office. The USPTO has given the EMUGEN trademark a serial number of 99735877. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 31, 2026. This trademark is owned by Emugen Therapeutics LLC. The EMUGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biological preparations, namely, gene therapy products for the treatment of Rett Syndrome, Dravet Syndrome, neurological diseases and disorders, central nervous system disease and disorders, and genetic diseases and disorders; Pharmaceutical preparations for gene replacement and gene regulation in diseases, disorders, and conditions affecting the brain and central nervous system; Drug delivery agents, namely, bioengineered adeno-associated virus vectors for delivering gene therapies across blood-brain barrier

Scientific research and development of new technologies and products in the field of gene therapy, neurology, neurobiology, and genetic medicine; Bioengineering of adeno-associated virus vectors for use in gene therapy, and other gene regulation and gene replacement technologies; Providing scientific research information in the field of gene therapy, neurology, neurobiology, genetic medicine, and drug delivery across blood-brain barrier
emugen

General Information

Serial Number99735877
Word MarkEMUGEN
Filing DateTuesday, March 31, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, March 31, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkEMU GENERATION
Goods and ServicesPharmaceutical and biological preparations, namely, gene therapy products for the treatment of Rett Syndrome, Dravet Syndrome, neurological diseases and disorders, central nervous system disease and disorders, and genetic diseases and disorders; Pharmaceutical preparations for gene replacement and gene regulation in diseases, disorders, and conditions affecting the brain and central nervous system; Drug delivery agents, namely, bioengineered adeno-associated virus vectors for delivering gene therapies across blood-brain barrier
Goods and ServicesScientific research and development of new technologies and products in the field of gene therapy, neurology, neurobiology, and genetic medicine; Bioengineering of adeno-associated virus vectors for use in gene therapy, and other gene regulation and gene replacement technologies; Providing scientific research information in the field of gene therapy, neurology, neurobiology, genetic medicine, and drug delivery across blood-brain barrier
Pseudo MarkEMU GEN

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 31, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 31, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmugen Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWoburn, MA 01801
US

Trademark Events

Event DateEvent Description
Tuesday, March 31, 2026NEW APPLICATION ENTERED
Tuesday, March 31, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

emugen gene therapy disorders brain diseases genetic across pharmaceutical delivery vectors